Investor Relations

Company Profile

Amphastar is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the Company sells insulin API products. Most of the Company’s finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers.

Company News

04Jun 2024

Amphastar Announces Additional $50 Million Increase to its Share Buyback Program

03Jun 2024

Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference


Financial Calendar

26Jun 2024

June 2024 Corporate Presentation

Add to Calendar
06Jun 2024

Jefferies Global Healthcare Conference

Add to Calendar

Email Alert

Subscribe to our newsletter

Spam protection: Please accept and solve the Captcha if prompted.